| ASTELLAS PHARMA INC. |
| Japan |
| Gesundheit |
| JP3942400007 / 856273 |
| YPH (Frankfurt) |
| FRA:YPH, ETR:YPH, YPH:GR |
| Nikkei225 |
| https://www.astellas.com/ |
|
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company formed in 2005 through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. It discovers, develops, manufactures, and commercializes innovative..
>Volltext.. |
| 26792.6 Mio. EUR |
| 27855.59 Mio. EUR |
| 13630.54 Mio. EUR |
| 4324.07 Mio. EUR |
| 2208.48 Mio. EUR |
| 1.23 EUR |
| 2433.58 Mio. EUR |
| 1364.36 Mio. EUR |
| 3170.15 Mio. EUR |
| 0.22 |
| 15.45% |
| 200.62% |
| 0.44 EUR |
| 3.01% |
| 3.09% |
| 29.09.26 - 0.22417599€ 30.03.26 - 0.21254103€ >weitere anzeigen... |
| - |
| ASTELLAS |
| 13.11.26 |
|